Source: OINDPnews

Juniper Pharmaceuticals: Catalent completes acquisition of Juniper Pharma Services

Catalent will continue to offer DPI development and manufacturing services at the Nottingham, UK Juniper Pharma Services facility that was part of its recently completed acquisition of Juniper Pharmaceuticals, the company says. Catalent announced its intent to acquire Juniper in July 2018. The Nottingham facility was originally owned by Molecular Profiles, which was acquired by [...]

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Alicia Secor's photo - President & CEO of Juniper Pharmaceuticals

President & CEO

Alicia Secor

CEO Approval Rating

78/100

Read more